-
Charge Detection Mass Spectrometry (CDMS): Unprecedented Direct Measurement for the Characterization of Mega-Mass Biomolecules
Whether you are analyzing adeno-associated viruses (AAVs) or virus-like particles, nucleic acids such as RNAs or lipid nanoparticles (LNPs), proteins, or protein complexes, simple and fit-for-purpose tools with speed, accuracy, and precision are essential for driving biotherapeutic innovations forward. In recent years, scientists have increasingly turned to charge detection mass spectrometry (CDMS).
Recent Posts
The Future of Biopharmaceutical Development Just Became Brighter
In late January, I traveled to WCBP (Well Characterized Biological Products), an industry conference that is hosted every year by the CASSS organization. It serves as a forum that brings together biopharmaceutical industry professionals and various regulatory agencies from around the world to review and discuss the current and future state of biopharmaceutical drug development....
Second Tier Newborn Screening Tests – Improving the Specificity of One of the Greatest Public Health Achievements
Newborn screening for inherited disorders has been heralded as one of the 10 greatest public health achievements of the first decade of the 21st century.1 The ability to pre-symptomatically identify newborn babies at risk of developing endocrine, hematologic, and metabolic disorders has dramatically improved or saved thousands of lives (and saved the healthcare system millions...
Method Lifecycle Management Survey Reveals Barriers and Enthusiasm for Change
Waters recently surveyed 100 method developers from innovator and generic pharmaceutical companies to better understand their existing challenges and views on Method Lifecycle Management (MLCM). We'll share with you the top questions and findings from our survey results.
Data Integrity Matters | Limiting Access to Tools That Could Be used to Manipulate Data (Part 3)
How do data integration and reintegration affect data integrity?
Enhancing Analytical Productivity by Breaking Down Silos – Part 3
Analytical data can be so much more than a historical point in time documented in a single report. In fact, biopharmaceutical organizations can use LC-MS data to build a continuum of compliance.
Future-Proofing Pharmaceutical R&D to Accelerate Aerosol Science Innovation
At Chiesi Group’s Chippenham laboratory in the UK, Waters’ UPLC systems with mass detection and informatics keep the team at the forefront of inhalation drug delivery products.
Popular Topics
ACQUITY QDa (17) bioanalysis (11) biologics (14) biopharma (26) biopharmaceutical (36) biotherapeutics (17) case study (17) chromatography (14) data integrity (22) food analysis (12) HPLC (15) LC-MS (22) liquid chromatography (LC) (20) mass detection (16) mass spectrometry (MS) (55) method development (13) STEM (12) sustainability (12)